Empire Industries Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026

1 min read     Updated on 07 Apr 2026, 12:41 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Empire Industries Limited submitted its compliance certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026. The certificate was filed with BSE Limited on April 7, 2026, with Bigshare Services Private Limited confirming proper handling of dematerialized securities and adherence to regulatory requirements during the quarter.

powered bylight_fuzz_icon
37091461

*this image is generated using AI for illustrative purposes only.

Empire Industries Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026.

Regulatory Filing Details

The compliance certificate was submitted on April 7, 2026, by S. C. Nanda, Director Finance & Company Secretary (ACS: 13703), to BSE Limited's Listing Compliances department. The filing pertains to the company's scrip code 509525 and addresses requirements under Regulation 74(5) of SEBI regulations.

Filing Parameter: Details
Quarter Ended: March 31, 2026
Filing Date: April 7, 2026
Scrip Code: 509525
Regulation: SEBI (Depositories and Participants) Regulations 2018
Signatory: S. C. Nanda, Director Finance & Company Secretary

Registrar Compliance Confirmation

Bigshare Services Private Limited, acting as the company's Registrar and Share Transfer Agent, provided the compliance certificate dated April 6, 2026. The registrar confirmed adherence to dematerialization procedures and securities handling requirements for the quarter.

The certificate validates that securities received from depository participants for dematerialization up to March 31, 2026, were properly confirmed to the depositories. Bigshare Services confirmed that all security certificates received for dematerialization were mutilated and cancelled after due verification by depository participants.

Compliance Procedures

Key compliance aspects covered in the certificate include:

  • Proper confirmation of securities to depositories (accepted/rejected)
  • Listing of securities on stock exchanges where earlier issued securities are listed
  • Mutilation and cancellation of security certificates after verification
  • Substitution of depository names in the register of members within 15 days of receipt

Company Information

Empire Industries Limited operates from its registered office at Empire Complex, 414 Senapati Bapat Marg, Lower Parel, Mumbai 400013. The company maintains diversified business divisions including Empire Machine Tools, Vitrum Glass, Empire Industrial Equipment, Empire Vending (GRABBIT), Empire Foods, The Empire Business Centre, and Empire Industrial Centrum.

The filing demonstrates the company's commitment to maintaining regulatory compliance and transparent corporate governance practices in accordance with SEBI guidelines for depositories and participants.

Historical Stock Returns for Empire Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-1.05%+9.08%-15.85%-14.18%+44.51%

Will Empire Industries' diversified business portfolio drive stronger financial performance in the upcoming quarters of 2026?

How might potential changes to SEBI's depositories regulations impact Empire Industries' compliance costs and operational procedures?

Could Empire Industries be planning any major corporate actions or restructuring given their emphasis on maintaining strict depositories compliance?

Empire Industries Appoints Hemant Kumar Bhardwaj as CEO of New Medtech Division

1 min read     Updated on 13 Mar 2026, 12:09 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Empire Industries Limited has appointed Mr. Hemant Kumar Bhardwaj as Divisional CEO of its proposed Medtech Division, effective March 13, 2026. Mr. Bhardwaj holds a Post-Graduation in Life Sciences from D.A.V.V. Indore and a Senior Leadership & Management Certificate from IIM-Indore, with extensive experience in strategic planning, leadership, and risk management in medical device business. This appointment marks Empire Industries' strategic expansion into the healthcare and medical technology sector, adding to its diverse portfolio of existing divisions across multiple industries.

powered bylight_fuzz_icon
34929558

*this image is generated using AI for illustrative purposes only.

Empire Industries Limited has announced the appointment of Mr. Hemant Kumar Bhardwaj as Divisional CEO of its proposed Medtech Division, effective March 13, 2026. The company informed BSE Limited about this senior management appointment in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Appointment Details

The appointment represents Empire Industries' strategic move into the medical technology sector. Mr. Bhardwaj will lead the newly proposed Medtech Division, marking the company's expansion into healthcare and medical device business operations.

Parameter: Details
Appointee: Mr. Hemant Kumar Bhardwaj
Position: Divisional CEO
Division: Proposed Medtech Division
Effective Date: March 13, 2026
Reason: New appointment

Professional Background

Mr. Bhardwaj brings significant expertise to his new role, with specialized experience in the medical device industry. His professional qualifications and experience include:

  • Education: Post-Graduation in Life Sciences from D.A.V.V. Indore, M.P.
  • Management Training: Senior Leadership & Management Certificate Course from IIM-Indore
  • Expertise Areas: Strategic planning, leadership experience, and risk management
  • Industry Focus: Medical device business and medtech operations

Company Portfolio Expansion

The addition of the Medtech Division expands Empire Industries' already diverse business portfolio. The company currently operates multiple divisions across various sectors:

  • Empire Machine Tools
  • Vitrum Glass
  • Empire Industrial Equipment
  • Empire Vending (GRABBIT)
  • Empire Foods
  • The Empire Business Centre
  • Empire Industrial Centrum

Regulatory Compliance

The appointment notification was filed in accordance with SEBI regulations, specifically Regulation 30(6) read with Para A(7) of Part A of Schedule III of the SEBI Listing Regulations and SEBI Circular No SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023. The company's communication was signed by Suhas Chandra Nanda, Director – Finance & Company Secretary.

This strategic appointment positions Empire Industries to capitalize on opportunities in the growing medical technology sector while leveraging Mr. Bhardwaj's specialized expertise in medtech operations and strategic leadership.

Historical Stock Returns for Empire Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-1.05%+9.08%-15.85%-14.18%+44.51%

More News on Empire Industries

1 Year Returns:-14.18%